Transcription co-factors SKI and SKIL protein partners

No Pathway Network information available for Transcription co-factors SKI and SKIL protein partners

Pathways in the Transcription co-factors SKI and SKIL protein partners SuperPath

#	Name	Source	Genes
1	Transcription co-factors SKI and SKIL protein partners	WikiPathways	HDAC1 HDAC3 ING2 LATS1 LATS2 MECP2 MERTK NF1 PRMT5 SATB2 SIN3A SKI SKIL STK3 (see all 14) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	LATS1	Large Tumor Suppressor Kinase 1	Protein Coding	1
2	HDAC3	Histone Deacetylase 3	Protein Coding	1
3	SKIL	SKI Like Proto-Oncogene	Protein Coding	1
4	SKI	SKI Proto-Oncogene	Protein Coding	1
5	NF1	Neurofibromin 1	Protein Coding	1
6	MECP2	Methyl-CpG Binding Protein 2	Protein Coding	1
7	HDAC1	Histone Deacetylase 1	Protein Coding	1
8	LATS2	Large Tumor Suppressor Kinase 2	Protein Coding	1
9	SIN3A	SIN3 Transcription Regulator Family Member A	Protein Coding	1
10	SATB2	SATB Homeobox 2	Protein Coding	1
11	MERTK	MER Proto-Oncogene, Tyrosine Kinase	Protein Coding	1
12	PRMT5	Protein Arginine Methyltransferase 5	Protein Coding	1
13	STK3	Serine/Threonine Kinase 3	Protein Coding	1
14	ING2	Inhibitor Of Growth Family Member 2	Protein Coding	1

Disorders associated with Transcription co-factors SKI and SKIL protein partners SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Malignant peritoneal mesothelioma	Enrichment	LATS1, LATS2	6.00
2	Autism spectrum disorder	Enrichment	MECP2, NF1, SATB2	3.76
3	Dystonia	Enrichment	MECP2, SATB2	3.24
4	Facial hypertrichosis	Enrichment	MECP2	2.99
5	Shprintzen-goldberg craniosynostosis syndrome	Enrichment	SKI	2.99
6	Intellectual developmental disorder, x-linked, syndromic, lubs type	Enrichment	MECP2	2.99
7	Autism x-linked 3	Enrichment	MECP2	2.99
8	Syndromic x-linked intellectual disability lubs type	Enrichment	MECP2	2.99
9	Plexiform neurofibroma	Enrichment	NF1	2.99
10	Neurofibroma	Enrichment	NF1	2.99
11	Neurofibromatosis	Enrichment	NF1	2.99
12	Chromosome 15q24 deletion syndrome	Enrichment	SIN3A	2.99
13	Chromosome 17q11.2 deletion syndrome	Enrichment	NF1	2.99
14	Optic nerve glioma	Enrichment	NF1	2.99
15	Myeloma, multiple	Enrichment	LATS1, NF1	2.83
16	Cafe-au-lait spots, multiple	Enrichment	NF1	2.69
17	Encephalopathy, neonatal severe, due to mecp2 mutations	Enrichment	MECP2	2.69
18	Chromosome 17q11.2 duplication syndrome, 1.4-mb	Enrichment	NF1	2.69
19	Intellectual developmental disorder, x-linked, syndromic 13	Enrichment	MECP2	2.69
20	X-linked intellectual disability-psychosis-macroorchidism syndrome	Enrichment	MECP2	2.69
21	Witteveen-kolk syndrome	Enrichment	SIN3A	2.69
22	Bardet-biedl syndrome 9	Enrichment	NF1	2.69
23	Retinitis pigmentosa 38	Enrichment	MERTK	2.69
24	Pleomorphic rhabdomyosarcoma	Enrichment	NF1	2.69
25	Progressive bulbar palsy	Enrichment	MECP2	2.69
26	Bruxism	Enrichment	MECP2	2.69
27	Laryngomalacia	Enrichment	MECP2	2.51
28	Watson syndrome	Enrichment	NF1	2.51
29	Glass syndrome	Enrichment	SATB2	2.51
30	Neurofibromatosis, familial spinal	Enrichment	NF1	2.51
31	Chromosome 17q11.2 deletion syndrome, 1.4-mb	Enrichment	NF1	2.51
32	Brain cancer	Enrichment	NF1	2.51
33	Neurofibromatosis-noonan syndrome	Enrichment	NF1	2.38
34	Embryonal rhabdomyosarcoma	Enrichment	NF1	2.38
35	Pilocytic astrocytoma	Enrichment	NF1	2.38
36	Sick sinus syndrome	Enrichment	MECP2	2.38
37	Middle aortic syndrome	Enrichment	NF1	2.38
38	Rhabdomyosarcoma 2	Enrichment	NF1	2.29
39	Goldberg-shprintzen syndrome	Enrichment	SKI	2.29
40	Angelman syndrome	Enrichment	MECP2	2.21
41	Microcephaly	Enrichment	MECP2, SATB2	2.16
42	Rett syndrome	Enrichment	MECP2	2.14
43	Focal epilepsy	Enrichment	MECP2	2.14
44	Ewing sarcoma	Enrichment	NF1	2.08
45	Rett syndrome, congenital variant	Enrichment	MECP2	2.08
46	Neurofibromatosis, type i	Enrichment	NF1	2.03
47	Leukemia, acute lymphoblastic 3	Enrichment	NF1	2.03
48	Juvenile myelomonocytic leukemia	Enrichment	NF1	1.91
49	Chromosome 1p36 deletion syndrome	Enrichment	SKI	1.87
50	Stereotypic movement disorder	Enrichment	MECP2	1.87
51	Pheochromocytoma	Enrichment	NF1	1.84
52	Rhabdomyosarcoma	Enrichment	NF1	1.79
53	Cleft palate, isolated	Enrichment	SATB2	1.76
54	Hereditary paraganglioma-pheochromocytoma syndromes	Enrichment	NF1	1.67
55	Attention deficit-hyperactivity disorder	Enrichment	MECP2	1.65
56	Skin disease	Enrichment	NF1	1.65
57	Rasopathy	Enrichment	NF1	1.58
58	Bladder cancer	Enrichment	NF1	1.53
59	Non-syndromic x-linked intellectual disability	Enrichment	MECP2	1.44
60	Systemic lupus erythematosus	Enrichment	MECP2	1.40
61	Epilepsy	Enrichment	MECP2	1.39
62	Gastric cancer	Enrichment	NF1	1.36
63	Familial thoracic aortic aneurysm and aortic dissection	Enrichment	SKI	1.35
64	Hereditary breast ovarian cancer syndrome	Enrichment	NF1	1.26
65	Autism	Enrichment	MECP2	1.14
66	Congenital nervous system abnormality	Enrichment	MECP2	0.98
67	Nervous system disease	Enrichment	MECP2	0.98
68	Inherited cancer-predisposing syndrome	Enrichment	NF1	0.89
69	Retinitis pigmentosa	Enrichment	MERTK	0.70
70	Hereditary retinal dystrophy	Enrichment	MERTK	0.58
71	Fundus dystrophy	Enrichment	MERTK	0.58

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Transcription co-factors SKI and SKIL protein partners

Pathway Network for Transcription co-factors SKI and SKIL protein partners

Member Pathways for Transcription co-factors SKI and SKIL protein partners

Pathways in the Transcription co-factors SKI and SKIL protein partners SuperPath

Associated Genes for Transcription co-factors SKI and SKIL protein partners

Associated Disorders for Transcription co-factors SKI and SKIL protein partners

Disorders associated with Transcription co-factors SKI and SKIL protein partners SuperPath

STRING Interaction Network for Transcription co-factors SKI and SKIL protein partners

Sources for Transcription co-factors SKI and SKIL protein partners